Research Article | Open Access
Soichiro Obata, Michi Kasai, Junko Kasai, Kazuo Seki, Zenjiro Sekikawa, Izumi Torimoto, Shigeo Takebayashi, Fumiki Hirahara, Shigeru Aoki, "Emergent Uterine Arterial Embolization Using N-Butyl Cyanoacrylate in Postpartum Hemorrhage with Disseminated Intravascular Coagulation", BioMed Research International, vol. 2017, Article ID 1562432, 7 pages, 2017. https://doi.org/10.1155/2017/1562432
Emergent Uterine Arterial Embolization Using N-Butyl Cyanoacrylate in Postpartum Hemorrhage with Disseminated Intravascular Coagulation
Although it is widely accepted that uterine artery embolization (UAE) is an effective therapeutic strategy for postpartum hemorrhage (PPH), no consensus has been reached regarding the efficacy of UAE in patients with PPH with disseminated intravascular coagulation (DIC). This single-center retrospective cohort study included patients treated with UAE using NBCA for PPH between 2010 and 2015. The patients were divided into DIC and non-DIC groups, according to the obstetrical DIC score and the overt DIC diagnostic criteria issued by the International Society of Thrombosis and Haemostasis (ISTH), and their clinical outcomes were compared. There were 28 patients treated with UAE using NBCA. Complete hemostasis was achieved by UAE in 19 of 28 patients. In eight of nine patients with unsuccessful hemostasis, surgical hemostatic interventions were performed after UAE, and hemostasis was achieved in seven patients. UAE using NBCA showed no significant intergroup differences in complete hemostasis according to the presence or absence of DIC based on obstetrical DIC score (70% versus 62.5%, ) or ISTH DIC score (54.5% versus 76.5%, ). UAE using NBCA may be a useful first-choice treatment for PPH with DIC.
Postpartum hemorrhage (PPH) remains one of the leading causes of maternal death , and it is widely accepted that uterine artery embolization (UAE) is an effective therapeutic strategy for PPH . On the other hand, no consistent view has been established regarding the efficacy and safety of UAE in patients with PPH with unstable maternal hemodynamics or disseminated intravascular coagulation (DIC). In 2012, Lee et al.  reported that although embolization performed in 251 patients with PPH resulted in a clinical success rate of 86.5% (217/251 patients), the rate was lower in those with DIC. Similarly, Kim et al.  reported in 2013 that the clinical success rate was low in patients with DIC, 37.5% of whom developed complications.
In previous reports, an absorbable gelatin sponge is a commonly used embolic material [3–5], whereas few reports have described the use of N-butyl-2-cyanoacrylate (NBCA), which does not depend on maternal clotting factors [6, 7]. At our hospital, NBCA is actively used in cases of UAE performed for patients with PPH with clinical signs of DIC. In this study, cases of UAE performed with NBCA in patients with PPH with DIC were retrospectively analyzed to evaluate the safety and efficacy.
2. Materials and Methods
This single-center retrospective cohort study included patients both with DIC and without DIC treated with UAE using NBCA for PPH between 2010 and 2015. These cases of UAE performed with NBCA for PPH at our hospital were retrieved from our perinatal database. UAE using NBCA was performed in 28 patients. The obstetrical DIC score  (Table 1) was determined in each patient, and patients with a score ≥ 8 were diagnosed with DIC. The patients were also evaluated with the overt DIC diagnostic criteria issued by the International Society of Thrombosis and Haemostasis (ISTH)  (Table 1), and those with a score ≥ 5 were diagnosed with DIC (Table 1). According to each scoring system, the patients were divided into DIC and non-DIC groups, and their baseline characteristics and clinical outcomes were compared. Primary PPH was defined as PPH occurring within 24 hours after delivery, while secondary PPH was defined as PPH occurring at or beyond 24 hours after delivery. Initially, the patients of PPH were managed by administration of uterine contraction agent, such as oxytocin or methylergometrine, and surgical intervention, if necessary, such as repairing genital tract lacerations, uterine compression suture, hysterectomy, or manual extraction placenta. UAE was performed after consultations with interventional radiologists when the obstetricians determined that hemostasis was difficult to achieve by obstetric management. UAE was performed even for patients with hemodynamic instability as well as those with hemodynamic stability.
|DIC, disseminated intravascular coagulation; ISTH, International Society of Thrombosis and Haemostasis.|
UAE was performed by two board-certified radiologists with 18 and 8 years of embolization experience. A 5-F shepherd hook catheter (Catex-CX, Gadelius Medical Co., Tokyo, Japan) or a 4-F cobra-head catheter (Terumo Co., Tokyo, Japan) was used. For the selective catheterization of the uterine artery, a 2.1-F microcatheter (Sniper 2, Terumo Co.) or 2.0-F high flow microcatheter (Bobsled, Clinical Supply Co., Yokohama, Japan) was passed through the parent catheter with a 0.016-inch microguidewire (Double Angle-Radifocus, Terumo Co.). NBCA (Histoacryl, B. Braun Melsungen, Germany) mixed with iodized oil (Lipiodol, Guerbet, Tokyo, Japan) at a ratio of 1 : 4 (20%) was usually used. Following a flush of 20% glucose, a 2.5 mL syringe containing 2.5 mL of 20% glue was connected to the microcatheter for the single-column injection technique. In the embolization of the internal iliac main trunk, the glue was infused through a 2.4-F coaxial catheter, of which the tip was placed in the anterior trunk and gradually pulled back in the main trunk with continuous infusion. The patients were admitted to the intensive care unit after the UAE and treated with antibiotics for ≥3 days. The regimens of antibiotics were determined by the attending obstetrician based on each patient’s condition.
The institutional perinatal database was used for a retrospective review of the included women’s medical charts. All patients were divided into the DIC cohorts and the non-DIC cohorts according to each obstetrical DIC scoring system and the ISTH DIC scoring system (Table 1). Patients’ backgrounds were compared between the DIC cohorts and the non-DIC cohorts each classified by the scoring system according to the following variables: the mean values of age, gestational age, time to UAE, procedure time of UAE, the volume of hemorrhage, the volume of each transfused fresh frozen plasma (FFP), and red blood cell (RBC). We also compared the incidences of patients with primipara, those with primary postpartum hemorrhage, those who underwent cesarean delivery, maternal transport in postpartum period, extravasation, and those with massive hemorrhage which was defined as a blood loss ≥ 2 L. The volume of blood loss was defined as the total volume of blood loss during a period from the delivery to the end of UAE. The effect of UAE was evaluated with regard to both complete hemostasis and efficacy of hemostasis. Complete hemostasis was defined as hemostasis achieved by UAE alone and requiring no additional hemostatic interventions. The efficacy of hemostasis was determined according to the number of cases of complete hemostasis and cases in which patients showed a decrease in DIC scores and underwent surgical intervention resulting in successful hemostasis. The time to UAE was defined as the time from a point when attending obstetricians recognized the need of UAE to the start of UAE in patients delivering at our hospital; in women transferred from other hospitals during the puerperal period, it was defined as the time from when obstetricians attending the delivery determined the transfer of their patients to our hospital for PPH control to the start of UAE. Furthermore, we also compared the frequencies of those with sepsis after UAE between the two patients groups. Sepsis was diagnosed in patients with positive blood cultures for samples obtained when a fever with a body temperature of ≥38°C developed after UAE.
This study was approved by the ethics committee of the Yokohama City University Medical Center (D1602001). We confirmed that the patients or the legal representatives of the patients in this study were given a comprehensive written statement of information about the clinical study, including information on UAE with NBCA-Lipiodol mixture, and their consent was documented in the clinical records.
IBM SPSS 23 statistical software (SPSS, Inc., Chicago, IL, USA) was used for the statistical analyses. The Mann–Whitney test was used to analyze continuous variables, and Fisher’s exact test was used to analyze intergroup differences in categorical data. The level of statistical significance was set at .
A flow chart of this study is shown in Figure 1. There were 28 patients treated with UAE using NBCA. The patients are summarized in Table 2 in terms of surgical intervention before UAE, embolized vessels, and presence or absence of DIC and extravasation. Of these patients, a surgical hemostatic intervention was first attempted in five patients, abdominal total hysterectomy (ATH) was attempted in three cases, and uterine compression suture and manual extraction of placenta were each attempted in one case, while UAE was first attempted in 23 patients. 18 patients in whom hypotension or tachycardia showed no response to the fluid resuscitation were transported directly to the angiographic suite in the obstetric emergency department. An indwelling intra-aortic balloon occlusion catheter was required in two of the 18 patients to maintain the blood pressure. In the remaining 10 patients, four patients were evaluated by contrasted enhanced computed tomography, and 3 patients showed extravasation and one patient showed pseudoaneurysm in uterus. Remaining 6 patients were not evaluated by computed tomography to avoid contrast material induced renal failure in the patients who had to be given contrast material on the UAE.
Complete hemostasis was achieved by UAE in 19 of 28 patients. In one of 9 patients with unsuccessful hemostasis, ATH was performed before UAE, and hemorrhage was difficult to control despite UAE, resulting in death. In the remaining 8 patients, surgical hemostatic interventions were performed after UAE. In four of these 8 patients, the obstetric DIC scores were decreased by UAE, whereas UAE made no clinical difference in the other four patients. The surgical hemostatic interventions performed included ATH in four patients, dilatation and curettage for a retained placenta in one patient, and laparotomy or transvaginal hemostatic intervention in three patients. Although one patient undergoing ATH died, hemostasis was achieved in the remaining seven patients who survived.
The results of comparison between the DIC and non-DIC groups according to the obstetrical DIC score are shown in Table 3. Twenty patients (71.4%) scored ≥8 points and were diagnosed with DIC. Although the gestational age was higher in the non-DIC group, no differences were observed in other variables, namely, maternal age, primipara rate, cesarean delivery rate, proportion of patients with primary PPH, proportion of patients transferred from other hospitals, time to UAE, procedure time of UAE, and presence or absence of extravasation. Complete hemostasis was achieved by UAE alone in 14/20 patients (70%) in the DIC group and 5/8 patients (62.5%) in the non-DIC group, although the difference between the groups was not significant (). The efficacy of hemostasis was confirmed in 17/20 (85%) and 6/8 (75%) patients, respectively, which also did not differ (). In maternal mortality, which occurred in 2/20 patients (10%) in the DIC group and 0/8 patients (0%) in the non-DIC group, no statistically significant difference was observed (). There were no significant differences in blood loss volume, blood transfusion volume, or maternal sepsis incidence.
DIC, disseminated intravascular coagulation; PPH, postpartum hemorrhage; UAE, uterine arterial embolization; FFP, fresh frozen plasma; RBC, red blood cells.
The results of the comparison of the DIC and non-DIC groups according to ISTH DIC score are shown in Table 4. Eleven patients (39.3%) scored ≥5 points and were diagnosed with DIC. Regarding maternal characteristics, no differences were observed in maternal age, gestational age, primipara rate, cesarean delivery rate, proportion of patients with primary PPH, proportion of patients transferred from other hospitals, time to UAE, or presence or absence of extravasation. A case of overt DIC in which complete hemostasis was achieved with UAE using NBCA is shown in Figures 2(a) and 2(b). Complete hemostasis was achieved with UAE alone in 6/11 patients (54.5%) in the DIC group and in 13/17 patients (76.5%) in the non-DIC group, although the difference between the groups was not significant (). The efficacy of hemostasis was confirmed in 8/11 (72.7%) and 15/17 (88.2%) patients, respectively, the difference between which was not significant (). In maternal mortality, which occurred in 2/11 patients (18.2%) in the DIC group and 0/17 patients (0%) in the non-DIC group, no statistically significant difference was observed (). Although the doses of fresh frozen plasma and red blood cells were higher in the DIC group ( and , resp.), no differences were observed in blood loss volume or maternal sepsis incidence.
DIC, disseminated intravascular coagulation; PPH, postpartum hemorrhage; UAE, uterine arterial embolization; FFP, fresh frozen plasma; RBC, red blood cells.
There were no cases of complication related to UAE such as uterine necrosis, distal embolization, and hematoma at punctual site.
UAE using NBCA performed for PPH achieved complete hemostasis in 19/28 patients (67.9%) and exhibited hemostasis efficacy in 23/28 patients (82.1%). This procedure demonstrated therapeutic efficacy. Moreover, its efficacy as indicated by complete hemostasis and efficacy of hemostasis did not differ between groups according to obstetrical DIC score and ISTH DIC score. The survival rate was 93% (26/28 patients). In the two cases of maternal death, both patients had developed an amniotic fluid embolism before transfer to our hospital, and irreversible DIC was observed on their arrival. One patient who presented with near-cardiopulmonary arrest on her arrival underwent UAE before surgical intervention, while another patient underwent ATH before UAE. However, hemostasis was not achieved in either case, and both patients died.
UAE using NBCA showed no significant intergroup differences in complete hemostasis or efficacy according to the presence or absence of DIC based on obstetrical DIC score or ISTH DIC score. This procedure was effective in patients with PPH with DIC. PPH often rapidly leads to DIC. Thus, not only the commonly used ISTH DIC score but also the obstetrical DIC score, which rates severity according to clinical symptoms, is used for treatment decisions. In this study, all patients diagnosed with DIC according to ISTH DIC score were also diagnosed with DIC according to obstetrical DIC score, and no intergroup differences in therapeutic efficacy were observed according to either DIC score. In general, if coagulopathy is present, it should be corrected before the procedure. In particular, elective interventional procedures are considered relatively contraindicated under coagulopathy. In fact, two series demonstrated that DIC was a risk factor for failure of embolization to control hemorrhage [3, 10]. Lee et al.  reported that the success rates of interventional radiology were 86.4% (217/251 patients) for PPH and 62.5% (20/32 patients) for PPH complicated by overt DIC, while Cheong et al.  reported that the success rates were 88.0% (103/117 patients) and 75.8% (25/33 patients), respectively. They reported that hemostasis rates were lower in patients with DIC. However, in these previous reports, they prefer to choose absorbable gelatin sponge as embolization material, while we prefer to use NBCA, which is immediate and permanent embolic agent and its embolic effect can be achieved independent of patients’ clotting function. The hemostasis rates in our study are comparable with those in these reports. However, in our study, UAE was the first choice even for patients with a hemodynamically and hemostatically unstable condition, while UAE was used for patients with a more severe condition than those described in their reports. Although this might have been responsible for the lower overall response rates as indicated by complete hemostasis achieved in 19/28 patients (67.9%) and efficacy of hemostasis observed in 23/28 patients (82.1%) in our study, our study did not show any differences in the hemostasis rate regardless of the presence or absence of DIC. Thus, our findings suggest that UAE with NBCA is highly effective for hemostasis in patients with PPH accompanied by DIC and might be a first-choice therapeutic strategy, especially for patients requesting fertility preservation.
This study has several limitations. First, because it included many patients who delivered babies at other hospitals, different protocols were used to treat PPH and the clinical courses prior to arrival at our hospital varied substantially among the patients. Moreover, even in patients whose treatment of PPH started at our hospital, decisions on which procedure, surgical interventions, or UAE was prioritized were left to each obstetrician’s discretion, and the obstetricians did not follow the same protocol. Finally, the sample size of 28 was small.
UAE using NBCA has its disadvantages including higher costs compared to UAE using conventional embolic materials and the need for operators to accurately determine the occlusion site . Moreover, although it has been reported that pregnancy after UAE using NBCA follows a normal course and results in a normal delivery , the impact of the procedure on a subsequent pregnancy is still unknown. However, the response rate achieved by UAE with NBCA for PPH with coagulopathy was comparable with the corresponding rate for PPH without coagulopathy.
Emergency UAE using NBCA may be a useful first-choice treatment for PPH with DIC.
The authors declare that they have no competing interests.
- K. S. Khan, D. Wojdyla, L. Say, A. M. Gülmezoglu, and P. F. Van Look, “WHO analysis of causes of maternal death: a systematic review,” Lancet, vol. 367, no. 9516, pp. 1066–1074, 2006.
- M. Gonsalves and A. Belli, “The role of interventional radiology in obstetric hemorrhage,” CardioVascular and Interventional Radiology, vol. 33, no. 5, pp. 887–895, 2010.
- H. Y. Lee, J. H. Shin, J. Kim et al., “Primary postpartum hemorrhage: outcome of pelvic arterial embolization in 251 patients at a single institution,” Radiology, vol. 264, no. 3, pp. 903–909, 2012.
- Y.-J. Kim, C. J. Yoon, N. J. Seong et al., “Failed pelvic arterial embolization for postpartum hemorrhage: clinical outcomes and predictive factors,” Journal of Vascular and Interventional Radiology, vol. 24, no. 5, pp. 703–709, 2013.
- D. Urushiyama, T. Yoshizato, S. Kora et al., “Predictive factors related to the efficacy of pelvic arterial embolization for postpartum hemorrhage: a retrospective analysis of 21 cases,” Taiwanese Journal of Obstetrics and Gynecology, vol. 53, no. 3, pp. 366–371, 2014.
- K. J. Park, J. H. Shin, H.-K. Yoon, D.-I. Gwon, G.-Y. Ko, and K.-B. Sung, “Postpartum hemorrhage from extravasation or pseudoaneurysm: efficacy of transcatheter arterial embolization using n-butyl cyanoacrylate and comparison with gelatin sponge particle,” Journal of Vascular and Interventional Radiology, vol. 26, no. 2, pp. 154–161, 2015.
- S. Igarashi, S. Izuchi, Y. Ogawa et al., “N-butyl cyanoacrylate is very effective for massive haemorrhage during the perinatal period,” PLoS ONE, vol. 8, no. 10, Article ID e77494, 2013.
- T. Kobayashi, “Obstetrical disseminated intravascular coagulation score,” Journal of Obstetrics and Gynaecology Research, vol. 40, no. 6, pp. 1500–1506, 2014.
- F. H. Taylor, C.-H. Toh, W. K. Hoots, H. Wada, and M. Levi, “Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation: on behalf of the scientific subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haematostasis (ISTH),” Thrombosis and Haemostasis, vol. 86, no. 5, pp. 1327–1330, 2001.
- J. Y. Cheong, T. W. Kong, J. H. Son, J. H. Won, J. I. Yang, and H. S. Kim, “Outcome of pelvic arterial embolization for postpartum hemorrhage: a retrospective review of 117 cases,” Obstetrics & Gynecology Science, vol. 57, no. 1, pp. 17–27, 2014.
- M. Kanematsu, H. Watanabe, H. Kondo et al., “Postpartum hemorrhage in coagulopathic patients: preliminary experience with uterine arterial embolization with N-butyl cyanoacrylate,” Journal of Vascular and Interventional Radiology, vol. 22, no. 12, pp. 1773–1776, 2011.
Copyright © 2017 Soichiro Obata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.